Your browser doesn't support javascript.
loading
Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis.
Li, Jiyifan; Zhu, Chenyang; Liang, Jingru; Hu, Jiarong; Liu, Haiyang; Wang, Zihan; Guan, Ruifang; Chow, Junwei; Yan, Shiwei; Li, Longzhou; Ma, Fuyan; Ma, Guo.
Affiliation
  • Li J; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
  • Zhu C; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
  • Liang J; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
  • Hu J; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
  • Liu H; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
  • Wang Z; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
  • Guan R; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
  • Chow J; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
  • Yan S; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
  • Li L; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
  • Ma F; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
  • Ma G; Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
Front Pharmacol ; 14: 1303694, 2023.
Article in En | MEDLINE | ID: mdl-38044937

Full text: 1 Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Front Pharmacol Year: 2023 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Front Pharmacol Year: 2023 Type: Article Affiliation country: China